Showing results (111-120 of 179) with videos related to
Sort By:
Pageof 18
Annals of the New York Academy of Sciences|December 17, 2011
Measuring intranodal pressure and lymph viscosity to elucidate mechanisms of arthritic flare and therapeutic outcomesEchoe M Bouta, Ronald W Wood, Seth W Perry, et al.Plos One|September 17, 2013
Power Doppler ultrasound phenotyping of expanding versus collapsed popliteal lymph nodes in murine inflammatory arthritisEchoe M Bouta, Yawen Ju, Homaira Rahimi, et al.Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2015
Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid ArthritisNida Meednu, Hengwei Zhang, Teresa Owen, et al.Nature Communications|June 28, 2019
TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosisJinbo Li, Akram Ayoub, Yan Xiu, et al.International Journal of Oncology|July 23, 2014
Bortezomib prevents oncogenesis and bone metastasis of prostate cancer by inhibiting WWP1, Smurf1 and Smurf2Zhiyu Wang, Juan Wang, Xing Li, et al.Beilstein Journal of Nanotechnology|January 1, 2015
Anticancer efficacy of a supramolecular complex of a 2-diethylaminoethyl-dextran-MMA graft copolymer and paclitaxel used as an artificial enzymeYasuhiko Onishi, Yuki Eshita, Rui-Cheng Ji, et al.Drug Delivery and Translational Research|March 20, 2015
Medicinal facilities to B16F10 melanoma cells for distant metastasis control with a supramolecular complex by DEAE-dextran-MMA copolymer/paclitaxelYuki Eshita, Rui-Cheng Ji, Masayasu Onishi, et al.Drug Discovery Today|June 8, 2018
Supermolecular drug challenge to overcome drug resistance in cancer cellsYasuhiko Onishi, Yuki Eshita, Rui-Cheng Ji, et al.Arthritis & Rheumatology (Hoboken, N.J.)|August 26, 2018
Attenuated Joint Tissue Damage Associated With Improved Synovial Lymphatic Function Following Treatment With Bortezomib in a Mouse Model of Experimental Posttraumatic OsteoarthritisWensheng Wang, Xi Lin, Hao Xu, et al.Arthritis and Rheumatism|July 27, 2012
Mechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: implications for insufficiency fracture riskMasahiko Takahata, Jason R Maher, Subhash C Juneja, et al.Pageof 18